Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators. Arora S, et al. Among authors: dellgren g. Am J Transplant. 2015 Jul;15(7):1967-75. doi: 10.1111/ajt.13214. Epub 2015 Mar 17. Am J Transplant. 2015. PMID: 25783974 Free article. Clinical Trial.
Successful heart transplantation from a donor with takotsubo syndrome.
Redfors B, Råmunddal T, Oras J, Karason K, Ricksten SE, Dellgren G, Omerovic E. Redfors B, et al. Among authors: dellgren g. Int J Cardiol. 2015 Sep 15;195:82-4. doi: 10.1016/j.ijcard.2015.05.137. Epub 2015 May 22. Int J Cardiol. 2015. PMID: 26025864 No abstract available.
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE investigators. Andreassen AK, et al. Among authors: dellgren g. Am J Transplant. 2016 Apr;16(4):1238-47. doi: 10.1111/ajt.13588. Epub 2016 Jan 28. Am J Transplant. 2016. PMID: 26820618 Free article. Clinical Trial.
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial.
Gullestad L, Eiskjaer H, Gustafsson F, Riise GC, Karason K, Dellgren G, Rådegran G, Hansson L, Gude E, Bjørtuft Ø, Jansson K, Schultz HH, Solbu D, Iversen M. Gullestad L, et al. Among authors: dellgren g. Transpl Int. 2016 Jul;29(7):819-29. doi: 10.1111/tri.12783. Epub 2016 May 30. Transpl Int. 2016. PMID: 27067532 Free article. Clinical Trial.
Transplantation after ex vivo lung perfusion: A midterm follow-up.
Wallinder A, Riise GC, Ricksten SE, Silverborn M, Dellgren G. Wallinder A, et al. Among authors: dellgren g. J Heart Lung Transplant. 2016 Nov;35(11):1303-1310. doi: 10.1016/j.healun.2016.05.021. Epub 2016 May 31. J Heart Lung Transplant. 2016. PMID: 27381674
Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
Bartfay SE, Dellgren G, Lidén H, Holmberg M, Gäbel J, Redfors B, Bech-Hanssen O, Karason K. Bartfay SE, et al. Among authors: dellgren g. J Thorac Cardiovasc Surg. 2017 Feb;153(2):360-367.e1. doi: 10.1016/j.jtcvs.2016.09.084. Epub 2016 Nov 15. J Thorac Cardiovasc Surg. 2017. PMID: 27955912 Free article.
155 results